High Efficiency of Low Dose Preparations of an Inactivated Lumpy Skin Disease Virus Vaccine Candidate
Capripox virus-induced diseases are commonly described as the most serious poxvirus diseases of production animals, as they have a significant impact on national and global economies. Therefore, they are classified as notifiable diseases under the guidelines of the World Organization for Animal Heal...
Main Authors: | Janika Wolff, Martin Beer, Bernd Hoffmann |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-06-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/10/7/1029 |
Similar Items
-
Development of a Safe and Highly Efficient Inactivated Vaccine Candidate against Lumpy Skin Disease Virus
by: Janika Wolff, et al.
Published: (2020-12-01) -
Minimum Infective Dose of a Lumpy Skin Disease Virus Field Strain from North Macedonia
by: Janika Wolff, et al.
Published: (2020-07-01) -
Cross-Protection of an Inactivated and a Live-Attenuated Lumpy Skin Disease Virus Vaccine against Sheeppox Virus Infections in Sheep
by: Janika Wolff, et al.
Published: (2023-03-01) -
Thermal Inactivation of Different Capripox Virus Isolates
by: Janika Wolff, et al.
Published: (2020-12-01) -
Characterization of a Nigerian Lumpy Skin Disease Virus Isolate after Experimental Infection of Cattle
by: Janika Wolff, et al.
Published: (2021-12-01)